🇺🇸 FDA
Patent

US 9950044

Treatment of pulmonary vascular remodeling with neprilysin

granted A61KA61K31/7088A61K38/4886

Quick answer

US patent 9950044 (Treatment of pulmonary vascular remodeling with neprilysin) held by The Regents of the University of Colorado, a Body Corporate expires Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Apr 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/7088, A61K38/4886, A61K48/00, A61K48/005